Pseudomonas aeruginosa Co-culture Is Associated with a Preconditioning-like Transcriptomic Shift in Acinetobacter baumannii
This study demonstrates that co-culturing *Acinetobacter baumannii* with *Pseudomonas aeruginosa* induces a preconditioning-like transcriptomic shift, characterized by the pre-activation or pre-repression of specific genes that subsequently attenuate the bacterium's response to subinhibitory antibiotic treatment.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
In the microscopic world of a human infection, bacteria rarely travel alone. They often form mixed communities, living side-by-side with other species in a complex social environment. This reality complicates how we understand disease and treatment. When doctors prescribe antibiotics, they usually test how a single type of bacteria reacts to the drug in isolation, much like testing a single runner on a track. However, inside the body, bacteria interact with neighbors that can change their behavior, their growth, and even their ability to survive medicine. Two of the most dangerous bacteria causing hospital infections are Acinetobacter baumannii and Pseudomonas aeruginosa. Both are notorious for developing resistance to multiple drugs, making them extremely difficult to kill. Scientists have long suspected that when these two species grow together, they alter each other's biology, but the specific molecular changes that happen during this interaction have remained largely a mystery. Understanding these hidden shifts is crucial because a treatment that works in a lab dish might fail in a patient if the bacteria's behavior changes simply because they are living with a neighbor.
A team of researchers set out to map these invisible changes by growing the two bacteria together in a controlled environment and observing their genetic activity. They used a specific combination of two antibiotics, imipenem and rifampicin, which had shown promise in earlier tests for working together to kill these bacteria. The scientists grew the bacteria in two ways: alone in separate containers and mixed together in the same container. They then exposed some of these cultures to a low dose of the antibiotic combination, a level strong enough to stress the bacteria but not strong enough to kill them immediately. By using advanced sequencing technology, the team read the genetic instructions of both bacteria at the same time, separating the signals from each species to see exactly how their genes turned on or off in response to the drug and to each other.
The results revealed a striking difference between the two species. When Pseudomonas aeruginosa grew with its neighbor, its reaction to the antibiotic remained largely the same as when it grew alone. It responded to the drug in a predictable way, turning on specific defense genes regardless of who was nearby. In contrast, Acinetobacter baumannii behaved very differently. When it grew alone, the antibiotic triggered a massive surge in gene activity, a typical stress response. But when it grew alongside Pseudomonas, the bacteria seemed to have already prepared for the attack before the drug was even added. The presence of the neighbor had shifted the baseline state of Acinetobacter, causing it to turn on certain genes early, so that when the antibiotic arrived, the bacteria did not need to react as strongly. It was as if the neighbor had given the bacteria a head start, changing its internal state so that the drug felt less shocking.
This phenomenon, which the researchers describe as a "preconditioning-like" shift, was not just a minor adjustment; it involved hundreds of genes. The team identified nearly three hundred genes in Acinetobacter that changed their behavior specifically because the bacteria were in a mixed culture. Many of these genes were involved in making ribosomes, the tiny machines inside cells that build proteins. In a normal, single-species culture, the antibiotic caused a sharp increase in the activity of these ribosome genes. However, in the mixed culture, these genes were already highly active before the drug was introduced, and the drug caused no further increase. The bacteria had essentially pre-loaded their protein-making machinery. Another group of genes, related to how the bacteria scavenge iron from their environment, showed a similar pattern. The neighbor caused these genes to turn on, but the antibiotic then turned them back down, a response that did not happen when the bacteria were alone.
The researchers were careful to ensure these findings were not just an artifact of the experiment, such as having fewer bacteria of one type to study. They performed rigorous checks, removing data points and simulating different conditions to confirm that the pattern held true. They found that the shift was robust and consistent. The study suggests that the presence of Pseudomonas fundamentally alters the starting point for Acinetobacter, moving it closer to a state that usually only occurs after antibiotic exposure. This means that the bacteria are not just reacting to the drug differently; they are living in a different biological state to begin with.
This discovery highlights a critical gap in how we study bacterial infections. Most laboratory tests look at bacteria in isolation, assuming that what happens in a single-species dish will happen in a complex infection. This study shows that assumption can be misleading. The interaction between species can reshape how a bacterium perceives and responds to treatment, potentially making it harder to predict which drugs will work. While the researchers did not prove that this specific shift makes the bacteria more resistant to the drug in a clinical setting, they demonstrated that the genetic landscape of the infection is far more dynamic than previously thought. The bacteria are not static targets; they are constantly adapting to their neighbors, and those adaptations change the rules of engagement for any antibiotic introduced into the mix. Understanding these silent conversations between bacteria is a necessary step toward developing better strategies to fight infections that involve multiple species.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.